NCT03803878

Brief Summary

The study is to translate the Medical, Epidemiologic, and Social aspects of Aging (MESA) urinary incontinence questionnaire into a Chinese language version and test the reliability and validity among women with urgency-predominant mixed urinary incontinence. The hypothesis is that the Chinese language version of the MESA questionnaire will have adequate measurement properties (e.g. reliability and validity).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 15, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

3.5 years

First QC Date

January 11, 2019

Last Update Submit

September 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The criteria validity of MESA questionnaire compared with extended clinical evaluation in deciding predominant components of MUI.

    The extended clinical evaluation mainly includes physical examination, 3-day voiding diary, cough stress teat, urinalysis and residual urine volume by ultrasonography.

    screening and baseline periods

Secondary Outcomes (4)

  • The criteria validity of MESA questionnaire compared with International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) in severity assessing among women with urgency-predominant mixed urinary incontinence.

    baseline

  • The criteria validity of MESA questionnaire compared with 3-day voiding diary in severity assessing among women with urgency-predominant mixed urinary incontinence.

    baseline

  • The test-retest reliability of MESA questionnaire

    screening and baseline periods

  • The responsiveness of MESA questionnaire

    baseline, week 12

Study Arms (3)

Group 1

Group 1 is anticipated to consist of 300 women with MUI, and the categorization function of MESA questionnaire will be validated among those patients.

Group 2

Group 2 is anticipated to consist of 282 women with urgency-predominant MUI.

Group 3

Group 3 is anticipated to consist of 94 women with urgency-predominant MUI.

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The questionnaire validation is targeted at women with urgency-predominant mixed urinary incontinence.

You may qualify if:

  • Female patients diagnosed with MUI in accordance with EAU guideline by history taking, physical examination, laboratory tests and specialist diagnosis;
  • Age between 18 and 80 years old;
  • At least 4 episodes of UUI in 3-day voiding diary;
  • With MUI for at least 3 months, and urgency urinary incontinence dominates more than 50% of the total incontinence episodes in 3-day voiding diary;
  • Positive cough test;

You may not qualify if:

  • Having pure SUI, pure UUI, overflow UI or neurogenic bladder;
  • Uncontrolled urinary tract infection;
  • Tumor in urinary system or pelvic organs;
  • Pelvic organ prolapse≥degreeⅡ;
  • Residual urine volume≥100ml;
  • Maximum flow rate\<15ml/s;
  • In the past 1 month, receiving treatment of acupuncture or positive medications targeted at incontinence, such as antimuscarinic drugs;
  • Underwent anti-incontinence or pelvic organ surgery, including metrectomy;
  • Complication of severe diabetes or hypertension;
  • Complication of diseases in nervous system that could hamper hypourethral function, such as multiple sclerosis, senile dementia, Parkinson's disease, spinal cord injury, cauda equina nerve injury and multiple system atrophy;
  • Severe complications in cardiac, lungs, cerebrum, hepar, renal system, psychonosology and coagulation function, or obvious cognitive disability;
  • Installed a cardiac pacemaker;
  • Allergic to Solifenacin or with contraindications to antimuscarinic drug, including urinary retention, gastrointestinal peristalsis paralysis, myasthenia gravis, ulcerative colitis and angle-closure glaucoma;
  • Allergic to metal or intolerant to the stimulation of electroacupuncture;
  • Pregnant or plan to conceive in the future 1 year, or delivery in the past one year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guang An Men Hospital

Beijing, 100053, China

RECRUITING

Related Publications (1)

  • Sun Y, Liu Y, Su T, Yuan J, Liu Z. Medical, epidemiologic, and social aspects of aging urinary incontinence questionnaire: Study protocol for the translation and validation of a Chinese language version. Medicine (Baltimore). 2019 Nov;98(44):e17719. doi: 10.1097/MD.0000000000017719.

Study Officials

  • Zhishun Liu, PhD

    Guang An Men Hospital

    STUDY CHAIR

Central Study Contacts

Yuanjie Sun, Master

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

January 11, 2019

First Posted

January 15, 2019

Study Start

March 1, 2019

Primary Completion

August 30, 2022

Study Completion

December 30, 2022

Last Updated

September 16, 2020

Record last verified: 2020-09

Locations